168 related articles for article (PubMed ID: 37470768)
1. Rate of Change in 10-Year Atherosclerotic Cardiovascular Disease Risk and Its Implications for Primary Prevention.
Hwang IC; Kim CH; Kim JY; Choi HM; Yoon YE; Cho GY
Hypertension; 2023 Aug; 80(8):1697-1706. PubMed ID: 37470768
[TBL] [Abstract][Full Text] [Related]
2. Is carotid artery evaluation necessary for primary prevention in asymptomatic high-risk patients without atherosclerotic cardiovascular disease?
Kim G; Youn HJ; Choi YS; Jung HO; Chung WS; Kim CM
Clin Interv Aging; 2015; 10():1111-9. PubMed ID: 26185430
[TBL] [Abstract][Full Text] [Related]
3. Impact of outcome definitions on cardiovascular risk prediction in a contemporary primary prevention population.
Sud M; Chu A; Austin PC; Naimark DM; Thanassoulis G; Wijeysundera HC; Ko DT
Eur Heart J Qual Care Clin Outcomes; 2023 Jun; 9(4):427-434. PubMed ID: 35904312
[TBL] [Abstract][Full Text] [Related]
4. High-Sensitivity C-Reactive Protein Discordance With Atherogenic Lipid Measures and Incidence of Atherosclerotic Cardiovascular Disease in Primary Prevention: The ARIC Study.
Quispe R; Michos ED; Martin SS; Puri R; Toth PP; Al Suwaidi J; Banach M; Virani SS; Blumenthal RS; Jones SR; Elshazly MB
J Am Heart Assoc; 2020 Feb; 9(3):e013600. PubMed ID: 32013698
[TBL] [Abstract][Full Text] [Related]
5. Clinical Application of High-Sensitivity Troponin Testing in the Atherosclerotic Cardiovascular Disease Framework of the Current Cholesterol Guidelines.
Marston NA; Bonaca MP; Jarolim P; Goodrich EL; Bhatt DL; Steg PG; Cohen M; Storey RF; Johanson P; Wiviott SD; Braunwald E; Sabatine MS; Morrow DA
JAMA Cardiol; 2020 Nov; 5(11):1255-1262. PubMed ID: 32756916
[TBL] [Abstract][Full Text] [Related]
6. Association of Statin Use With All-Cause and Cardiovascular Mortality in US Veterans 75 Years and Older.
Orkaby AR; Driver JA; Ho YL; Lu B; Costa L; Honerlaw J; Galloway A; Vassy JL; Forman DE; Gaziano JM; Gagnon DR; Wilson PWF; Cho K; Djousse L
JAMA; 2020 Jul; 324(1):68-78. PubMed ID: 32633800
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and incidence of atherosclerotic cardiovascular disease and its risk factors in Korea: a nationwide population-based study.
Kim H; Kim S; Han S; Rane PP; Fox KM; Qian Y; Suh HS
BMC Public Health; 2019 Aug; 19(1):1112. PubMed ID: 31412823
[TBL] [Abstract][Full Text] [Related]
8. Prediction of the 10-year risk of atherosclerotic cardiovascular disease in the Korean population.
Park S; Kim YG; Ann SH; Cho YR; Kim SJ; Han S; Park GM
Epidemiol Health; 2023; 45():e2023052. PubMed ID: 37189276
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of atherosclerotic cardiovascular disease and subsequent major adverse cardiovascular events in Alberta, Canada: A real-world evidence study.
Chen G; Farris MS; Cowling T; Pinto L; Rogoza RM; MacKinnon E; Champsi S; Anderson TJ
Clin Cardiol; 2021 Nov; 44(11):1613-1620. PubMed ID: 34585767
[TBL] [Abstract][Full Text] [Related]
10. Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: the updated SMART2 algorithm.
Hageman SHJ; McKay AJ; Ueda P; Gunn LH; Jernberg T; Hagström E; Bhatt DL; Steg PG; Läll K; Mägi R; Gynnild MN; Ellekjær H; Saltvedt I; Tuñón J; Mahíllo I; Aceña Á; Kaminski K; Chlabicz M; Sawicka E; Tillman T; McEvoy JW; Di Angelantonio E; Graham I; De Bacquer D; Ray KK; Dorresteijn JAN; Visseren FLJ
Eur Heart J; 2022 May; 43(18):1715-1727. PubMed ID: 35165703
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular event rates in a high atherosclerotic cardiovascular disease risk population: estimates from Swedish population-based register data.
Lindh M; Banefelt J; Fox KM; Hallberg S; Tai MH; Eriksson M; Villa G; Svensson MK; Qian Y
Eur Heart J Qual Care Clin Outcomes; 2019 Jul; 5(3):225-232. PubMed ID: 30649251
[TBL] [Abstract][Full Text] [Related]
12. Extreme Atherosclerotic Cardiovascular Disease (ASCVD) Risk Recognition.
Rosenblit PD
Curr Diab Rep; 2019 Jul; 19(8):61. PubMed ID: 31332544
[TBL] [Abstract][Full Text] [Related]
13. Systematic Review for the 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
Wilson PWF; Polonsky TS; Miedema MD; Khera A; Kosinski AS; Kuvin JT
Circulation; 2019 Jun; 139(25):e1144-e1161. PubMed ID: 30586775
[TBL] [Abstract][Full Text] [Related]
14. Lowering Targeted Atherogenic Lipoprotein Cholesterol Goals for Patients at "Extreme" ASCVD Risk.
Rosenblit PD
Curr Diab Rep; 2019 Nov; 19(12):146. PubMed ID: 31754844
[TBL] [Abstract][Full Text] [Related]
15. Real-world risk of cardiovascular outcomes associated with hypertriglyceridaemia among individuals with atherosclerotic cardiovascular disease and potential eligibility for emerging therapies.
Lawler PR; Kotrri G; Koh M; Goodman SG; Farkouh ME; Lee DS; Austin PC; Udell JA; Ko DT
Eur Heart J; 2020 Jan; 41(1):86-94. PubMed ID: 31733058
[TBL] [Abstract][Full Text] [Related]
16. Association between change in cardiovascular risk scores and future cardiovascular disease: analyses of data from the Whitehall II longitudinal, prospective cohort study.
Lindbohm JV; Sipilä PN; Mars N; Knüppel A; Pentti J; Nyberg ST; Frank P; Ahmadi-Abhari S; Brunner EJ; Shipley MJ; Singh-Manoux A; Tabak AG; Batty GD; Kivimäki M
Lancet Digit Health; 2021 Jul; 3(7):e434-e444. PubMed ID: 34167764
[TBL] [Abstract][Full Text] [Related]
17. Value of Coronary Artery Calcium Scanning in Association With the Net Benefit of Aspirin in Primary Prevention of Atherosclerotic Cardiovascular Disease.
Ajufo E; Ayers CR; Vigen R; Joshi PH; Rohatgi A; de Lemos JA; Khera A
JAMA Cardiol; 2021 Feb; 6(2):179-187. PubMed ID: 33112372
[TBL] [Abstract][Full Text] [Related]
18. Utility of Nontraditional Risk Markers in Individuals Ineligible for Statin Therapy According to the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines.
Yeboah J; Polonsky TS; Young R; McClelland RL; Delaney JC; Dawood F; Blaha MJ; Miedema MD; Sibley CT; Carr JJ; Burke GL; Goff DC; Psaty BM; Greenland P; Herrington DM
Circulation; 2015 Sep; 132(10):916-22. PubMed ID: 26224808
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular Family History Increases the Risk of Disease Recurrence After a First Myocardial Infarction.
Wahrenberg A; Kuja-Halkola R; Magnusson PKE; Häbel H; Warnqvist A; Hambraeus K; Jernberg T; Svensson P
J Am Heart Assoc; 2021 Dec; 10(23):e022264. PubMed ID: 34845931
[TBL] [Abstract][Full Text] [Related]
20. Coronary artery calcium, hepatic steatosis, and atherosclerotic cardiovascular disease risk in patients with type 2 diabetes mellitus: Results from the Dallas heart study.
Khawaja T; Linge J; Leinhard OD; Al-Kindi SG; Rajagopalan S; Khera A; de Lemos JA; Joshi P; Neeland IJ
Prog Cardiovasc Dis; 2023; 78():67-73. PubMed ID: 36931545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
